Israel’s BioLight Life Sciences has completed a successful US clinical study designed to assess the effectiveness of a test evaluating tears’ components of patients suffering from dry eye syndrome, and Israeli startup SoniVie has a novel system for the treatment of pulmonary arterial hypertension.
Israel’s Teva is partnering with Japan’s Heptares to develop a treatment for migraines, and researchers at Ben Gurion University have discovered that sufferers of diabetic foot ulcers frequently also have substantially impaired cognitive function.
Join More than
12,327,915
United With Israel
You will receive updates from Israel (see privacy policy)